Lilly to sell obesity drugs directly on Hims & Hers site
Yahoo Finance · By Michael Erman ·
Nov 6 (Reuters) - Eli Lilly said on Friday it struck a deal to allow telehealth company Hims & Hers Health to sell obesity drugs Zepbound and Foundayo direc...
By Michael Erman
Nov 6 (Reuters) - Eli Lilly (LLY) said on Friday it struck a deal to allow telehealth company Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly on its platform.
Shares of Hims & Hers (HIMS) rose more than 7% in premarket trading.
Read the full story at Yahoo Finance · All coverage of this story